Insights on Life Sciences
Report
Generative AI in the pharmaceutical industry: Moving from hype to reality
-
The technology could offer pharma companies a once-in-a-century opportunity—but only if they learn to scale it and address the industry’s unique challenges.
Article
What to expect from medtech in 2024
-
Our medtech predictions for the year ahead were inspired by conversations with more than 200 industry leaders and informed by...
Article
Here to stay: An attractive future for medical aesthetics
-
The medical-aesthetics sector shows strong resilience and room for strategic innovations in business models, product portfolios,...
Article
Accelerating clinical trials to improve biopharma R&D productivity
-
Biopharma sponsors are seeking to accelerate clinical trials and reduce costs through a set of targeted actions aimed at improving...
Article
What early-stage investing reveals about biotech innovation
-
Public funding for biotech remains tenuous, but in 2022 and 2023 venture capitalists have continued to pour money into innovative...
Article
Digital diagnostics: A path forward for IVD
-
In vitro diagnostics players are being tested as their offerings are increasingly commoditized. Digital diagnostics offers a...
Article
How artificial intelligence can power clinical development
-
Artificial intelligence is accelerating drug discovery. If clinical development fails to keep pace, the benefits to patients...
Article
A vision for medical affairs 2030: Five priorities for patient impact
-
In 2018, we foresaw medical affairs playing a more strategic role and contributing greater patient impact. That future is now;...
Report
Medtech Pulse: Thriving in the next decade
-
Medtech leaders are devising strategies to catch the next wave of value creation amid uncertain macroeconomics and evolving industry...
Special collection
Future of pharma operations
Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.
Coronavirus vaccines progress: What’s next?
The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.
McKinsey insights on cell and gene therapy
Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.
The rise of health technology
Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.
More insights
Related Practices
Healthcare Systems & Services
Read our latest research, articles, and reports on Healthcare Systems & Services on the changes that matter most for the...
Consumer Health
The consumer-health industry is booming, driven by an aging population, a proliferation of wellness-related products and services,...
Public & Social Sector
Read our latest research, articles, and reports on Public & Social Sector.